Kyverna Therapeutics (KYTX) Capital Expenditures (2023 - 2025)
Kyverna Therapeutics posted quarterly Capital Expenditures of $5000.0 for Q4 2025, down 99.06% year-on-year from $532000.0 in Q4 2024, and up 225.0% on a QoQ basis from -$4000.0 in Q3 2025.
Kyverna Therapeutics (KYTX) has 3 years of Capital Expenditures data on file, last reported at $5000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures fell 99.06% year-over-year to $5000.0; the trailing twelve-month figure through Dec 2025 stood at $5000.0 (down 99.77% YoY), and the FY2025 full-year result was $5000.0, down 99.77% from the prior year.
- Capital Expenditures for Q4 2025 stood at $5000.0, up from -$4000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.7 million in Q3 2024 and bottomed at -$543000.0 in Q2 2024.
- The 3-year median for Capital Expenditures is $28000.0 (2023), against an average of $257363.6.
- Peak annual rise in Capital Expenditures reached 1839.29% in 2024, while the deepest fall reached 10760.0% in 2024.
- A 3-year view of Capital Expenditures shows it stood at $334000.0 in 2023, then surged by 59.28% to $532000.0 in 2024, then sank by 99.06% to $5000.0 in 2025.
- The last three Capital Expenditures figures came in at $5000.0 (Q4 2025), -$4000.0 (Q3 2025), and $4000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Kyverna Therapeutics | 497.98 Mn | 265.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Dec 31, 2024 | 532,000.00 |
| Dec 31, 2024 | 532,000.00 |
| Sep 30, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | -543,000.00 |
| Jun 30, 2024 | -543,000.00 |
| Mar 31, 2024 | 543,000.00 |
| Mar 31, 2024 | 543,000.00 |
| Dec 31, 2023 | 334,000.00 |
| Dec 31, 2023 | 334,000.00 |
| Sep 30, 2023 | 264,000.00 |
| Sep 30, 2023 | 264,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Mar 31, 2023 | 28,000.00 |
| Mar 31, 2023 | 28,000.00 |